Phase 2 Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing to take part voluntarily and have signed a consent form agreeing to follow the study requirements.
- People with ovarian cancer who have received platinum-based chemotherapy at Zhejiang Provincial People's Hospital, where the cancer either stayed stable or got worse after two rounds of treatment, and who are then treated with Fasudil alongside their existing chemotherapy, and whose genetic testing shows a specific gene type called A/A genotype.
Who may not be able to join:
- People who have low blood pressure.
- People who have experienced a type of bleeding in the brain, such as a cerebral hemorrhage.
- People who have abnormal liver function.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Yang Liu, M.D., Zhejiang Provincial People's Hospital
Phone: 13666601475
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
ORR
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.